Cory M. Hogaboam, PhD

Professor, Medicine

Cory M. Hogaboam, PhD

Cory M. Hogaboam, PhD

Professor, Medicine

The laboratory of Cory Hogaboam, PhD, is focused on elucidating innate and adaptive immune mechanisms that drive chronic lung diseases such as asthma, hypersensitivity pneumonitis, chronic obstructive pulmonary disease (COPD), and idiopathic interstitial pneumonias (IIPs; like idiopathic pulmonary fibrosis). Lab members are particularly interested in understanding the manner in which lung structural cells are impacted by these disease processes.

  • American Journal of Respiratory and Critical Care Medicine, Current
  • American Association of Asthma, Allergy & Immunology, 2013
  • Journal of Immunology, 2002-09
  • American Thoracic Society, 2002
  • American Society for Investigative Pathologists, 2001
  • Ellson CD, Dunmore R, Hogaboam CM, Sleeman MA, Murray LA. Danger-associated molecular patterns and danger signals in idiopathic pulmonary fibrosis. Am J Respir Cell Mol Biol. 2014 Aug;51(2):163-168.
  • Moreira AP, Cavassani KA, Ismailoglu UB, Hullinger R, Dunleavy MP, Knight DA, Kunkel SL, Uematsu S, Akira S, Hogaboam CM. The protective role of TLR6 in a mouse model of asthma is mediated by IL-23 and IL-17A. J Clin Invest. 2011 Nov;121(11):4420-4432.
  • Murray LA, Zhang H, Oak SR, Coelho AL, Herath A, Flaherty KR, Lee J, Bell M, Knight DA, Martinez FJ, Sleeman MA, Herzog EL, Hogaboam CM. Targeting interleukin-13 with tralokinumab attenuates lung fibrosis and epithelial damage in a humanized SCID idiopathic pulmonary fibrosis model. Am J Respir Cell Mol Biol. 2014 May;50(5):985-994.

English

Many of the physicians who have medical staff privileges to practice medicine at Cedars-Sinai Medical Center are independent physicians, and not employees or agents of the hospital. These independent physicians bill separately for their services. You should contact your physician to determine their status and billing practices.